ApoA1 exchange rate assays in serum
US12292451B2 · kind B2 · utility
0Cited by
1References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 3, 2019 |
| Grant date | May 6, 2025 |
| Priority date | — |
| Expiry date | Feb 27, 2042 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/775
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Provided herein are compositions, systems, kits, and methods for performing an apoA1 exchange assay to determine the risk of MACE and/or for conducting an action based on the assay results. In some embodiments, methods are provided for generating, or receiving, a report that graphically displays: i) the subjects ApoA1 exchange rate in a sample as lower than a control or threshold value, and ii) the subjects risk of a major adverse cardiac event (MACE) and/or cardiovascular disease as being higher than normal.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.